前往化源商城

5-(3-溴苯基)-3-甲基-1,2,4-恶二唑

更新时间:2025-08-25 18:19:40

5-(3-溴苯基)-3-甲基-1,2,4-恶二唑结构式
5-(3-溴苯基)-3-甲基-1,2,4-恶二唑结构式
品牌特惠专场
常用名 5-(3-溴苯基)-3-甲基-1,2,4-恶二唑 英文名 5-(3-bromophenyl)-3-methyl-1,2,4-oxadiazole
CAS号 160377-58-2 分子量 239.06900
密度 1.528g/cm3 沸点 340.8ºC at 760 mmHg
分子式 C9H7BrN2O 熔点 95ºC
MSDS N/A 闪点 159.9ºC

 5-(3-溴苯基)-3-甲基-1,2,4-恶二唑名称

中文名 5-(3-溴苯基)-3-甲基-1,2,4-恶二唑
英文名 5-(3-bromophenyl)-3-methyl-1,2,4-oxadiazole

 5-(3-溴苯基)-3-甲基-1,2,4-恶二唑物理化学性质

密度 1.528g/cm3
沸点 340.8ºC at 760 mmHg
熔点 95ºC
分子式 C9H7BrN2O
分子量 239.06900
闪点 159.9ºC
精确质量 237.97400
PSA 38.92000
LogP 2.80750
InChIKey CAJCGTZYHFBZAW-UHFFFAOYSA-N
SMILES Cc1noc(-c2cccc(Br)c2)n1
蒸汽压 0.000165mmHg at 25°C
折射率 1.577

 5-(3-溴苯基)-3-甲基-1,2,4-恶二唑MSDS

 5-(3-溴苯基)-3-甲基-1,2,4-恶二唑安全信息

海关编码 2934999090

 5-(3-溴苯基)-3-甲基-1,2,4-恶二唑合成线路

~%

5-(3-溴苯基)-3-甲基-1,2,4-恶二唑结构式

5-(3-溴苯基)-3-甲基-...

160377-58-2

文献:GLAXO GROUP LIMITED Patent: WO2006/40192 A1, 2006 ; Location in patent: Page/Page column 38 ; WO 2006/040192 A1

~%

5-(3-溴苯基)-3-甲基-1,2,4-恶二唑结构式

5-(3-溴苯基)-3-甲基-...

160377-58-2

文献:MERCK SHARP and DOHME CORP.; GILBERT, Eric, J.; CUMMING, Jared, N.; STAMFORD, Andrew, W.; YU, Younong; SCOTT, Jack, D.; ISERLOH, Ulrich; WANG, Lingyan; CALDWELL, John, P. Patent: WO2014/62553 A1, 2014 ; Location in patent: Page/Page column 56 ;

 5-(3-溴苯基)-3-甲基-1,2,4-恶二唑上下游产品

5-(3-溴苯基)-3-甲基-1,2,4-恶二唑上游产品  4

5-(3-溴苯基)-3-甲基-1,2,4-恶二唑下游产品  0

 5-(3-溴苯基)-3-甲基-1,2,4-恶二唑海关

海关编码 2934999090
中文概述 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:


查看所有供应商和价格请点击:

5-(3-溴苯基)-3-甲基-1,2,4-恶二唑生产厂家

5-(3-溴苯基)-3-甲基-1,2,4-恶二唑价格

相关化合物: 更多...
5-(4-Methoxynaphthalen-1-yl)-1,2-oxazol-3-amine
2229104-83-8
D-Streptamine, O-3,4,6-tri-O-acetyl-2-deoxy-2-(methylamino)-I+/--L-glucopyranosyl-(1a2)-O-3-O-acetyl-3-C-[(acetyloxy)methyl]-5-deoxy-I+/--L-lyxofuranosyl-(1a4)-N,Na(2)-bis[(acetylamino)(acetylimino)methyl]-, 2,5,6-triacetate
63487-74-1
1-(2-{Imidazo[1,2-a]pyrazin-3-yl}ethyl)cyclopropan-1-ol
2229629-78-9
2-(4,5-Dimethoxy-2-nitrophenyl)-8-[[4-[ethyl[2-[(methylsulfonyl)amino]ethyl]amino]-2-methylphenyl]amino]-4-hydroxy-4-oxido-8-oxo-3,5,7-trioxa-4-phosphaoct-1-yl hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoate
799247-55-5
I(2)-D-Glucopyranosiduronic acid, (3I(2),4I+/-,15I+/-,16I+/-,21I(2),22I+/-)-15,16,28-trihydroxy-23-methoxy-21-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-22-(2-methyl-1-oxobutoxy)-23-oxoolean-12-en-3-yl 3-O-I+/--L-arabinopyranosyl-, methyl ester
288153-02-6
I(2)-D-Glucopyranosiduronic acid, (3I(2),16I+/-,18I+/-)-13,28-epoxy-16-hydroxyoleanan-3-yl O-6-deoxy-I+/--L-mannopyranosyl-(1a2)-O-[O-6-deoxy-I+/--L-mannopyranosyl-(1a4)-6-deoxy-I+/--L-mannopyranosyl-(1a4)]-O-I(2)-D-glucopyranosyl-(1a4)
137682-21-4
6-[2-(5-Amino-2-hydroxyphenyl)diazenyl]-3-[2-[4-[[4-[2-[7-[2-(5-amino-2-hydroxyphenyl)diazenyl]-1-hydroxy-3-sulfo-2-naphthalenyl]diazenyl]phenyl]amino]-3-sulfophenyl]diazenyl]-4-hydroxy-2-naphthalenesulfonic acid
1180493-25-7
O-(N-Acetyl-I+/--neuraminosyl)-(2a6)-O-I(2)-D-galactopyranosyl-(1a4)-O-2-(acetylamino)-2-deoxy-I(2)-D-glucopyranosyl-(1a6)-O-[O-I(2)-D-galactopyranosyl-(1a3)-I(2)-D-galactopyranosyl-(1a3)]-O-I(2)-D-galactopyranosyl-(1a4)-D-glucose
1620062-43-2
D-myo-Inositol, 6-O-[2-(acetylamino)-2-deoxy-I(2)-D-glucopyranosyl]-2-deoxy-, 1-[(2S,3R,3aS,4S,4a(2)S,5a(2)R,6S,7aR)-4a(2)-(benzoyloxy)decahydro-3,3a,4-trihydroxy-5a(2)-methylspiro[benzofuran-2(3H),2a(2)-[2H]pyran]-6-carboxylate]
294864-89-4
I(2)-D-Glucopyranoside, 1-methyl-1-[[3-methyl-6-(1-methylethylidene)-2-cyclohexen-1-yl]methyl]-2-propenyl O-6-deoxy-I+/--L-mannopyranosyl-(1a6)-O-[O-6-deoxy-I+/--L-mannopyranosyl-(1a4)-6-deoxy-I+/--L-mannopyranosyl-(1a2)]
143376-49-2